ACNB Insider Filing: Director Compensation Adds 250.95 Shares
Rhea-AI Filing Summary
James J. Lott, a director of ACNB Corporation (ACNB), reported a non-derivative purchase of 250.948 shares of ACNB common stock with a transaction date of 09/15/2025 and a deemed execution date of 09/16/2025. The reported price per share was $44.83. Following the transaction, Mr. Lott beneficially owned 18,290.1057 shares in total. The filing states the shares were received as director compensation under a director compensation plan and that the total includes shares acquired via automatic dividend reinvestment under ACNB's Dividend Reinvestment and Stock Purchase Plan, which are exempt from Section 16 reporting. The Form 4 was signed by Kevin J. Hayes as POA on 09/17/2025.
Positive
- Director increased ownership by 250.948 shares through a purchase at $44.83, raising beneficial ownership to 18,290.1057 shares
- Acquisition tied to director compensation, indicating the transaction is a standard compensation-related grant rather than a sale
- Disclosure includes dividend reinvestment treatment, clarifying that some shares are exempt from Section 16 reporting
Negative
- None.
Insights
TL;DR: Routine director stock acquisition of 251 shares at $44.83 increases insider ownership modestly; no sales or material red flags.
The reported purchase of 250.948 shares is a routine insider acquisition tied to director compensation and dividend reinvestment. The transaction increases the director's beneficial stake to 18,290.1057 shares. Because the filing cites compensation and DRIP activity and shows no disposals or option exercises, this is a neutral, non-dilutive event that does not indicate a change in control or liquidity pressure.
TL;DR: Compliance filing appears standard; execution date noted per Rule 16a-3 and transaction signed by POA.
The Form 4 documents a standard equity grant/compensation-related acquisition for a director and correctly references SEC Rule 16a-3(g) timing. Inclusion of shares from the Dividend Reinvestment and Stock Purchase Plan is disclosed as exempt from Section 16 reporting. The signature by a power of attorney is properly shown, and no governance issues or unusual arrangements are evident from the filing text.